absci.com - יחס שווי כולל של החברה להכנסות ABSI

Absci performance remains independent of market cycles, relying on contracts with pharmaceutical giants. This GURU.Markets chart, presented as an EV/Sales multiple, illustrates the asset's reaction to the cost of capital, where 833973.15 captures the magnitude of this parameter. Absci synthesizes AI and biology to accelerate protein design, developing IT tools through strategic alliances and laboratory acquisitions.
ABSI (Absci Bio): פילוחים אנליטיים ודוחות לפי אינדיקטורים

The stable geopolitical status of Absci makes it an attractive asset for long-term capital. The EV/Sales metric assesses the market value of the business, including net debt, relative to sales volume. By analyzing the EV/Sales level of Absci, an investor determines the real value of production capacities without the influence of leverage. The humanitarian nature of biomedicine minimizes the volatility risks of this indicator, which confirms the fundamental stability of the business model.